General Announcement::Biocon Issuer Substitution

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
06-Jul-2026 13:54:51
Status
New
Announcement Sub Title
Biocon Issuer Substitution
Announcement Reference
SG260706OTHR52ON
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
06/07/2026 11:20:00
Description (Please provide a detailed description of the event in the box below)
Biocon Biologics Global PLC announces that it has received in-principle approval from the SGX-ST on 1 July 2026
with respect to its substitution by Biocon Biologics UK PLC (formerly known as Biosimilars Newco Limited)

Attachments

BBL_SGX_Biocon Issuer Substitution_06072026.pdf
Total size =225K